VAERS reports by lot

Pfizer COVID-19 lot NA4457: VAERS reports

72 VAERS reports list lot NA4457 as a Pfizer COVID-19 vaccine, received between 2025-10-13 and 2026-04-14. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
72
Reports
1%
Marked serious
1
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5322%
Neurological5222%
General / Systemic (non-local)3414%
Cardiac / Cardiovascular208%
Musculoskeletal167%
Dermatological (non-injection-site)156%
Allergic / Anaphylactic146%
Gastrointestinal125%
Psychiatric / Neuropsychiatric115%
Respiratory104%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Florida12
California7
Massachusetts5
Pennsylvania5
New York4
Illinois4
Georgia3
North Carolina3
Virginia2
Maryland2
Michigan2
Missouri2

Reports by month received

MonthReportsBar
2025-1023
2025-1129
2025-1211
2026-013
2026-024
2026-031
2026-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): NA0739 · NA0846 · NA4452 · NA4459 · NE4289 · NJ6625

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.